130 related articles for article (PubMed ID: 1576489)
41. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
[TBL] [Abstract][Full Text] [Related]
42. Assessment of resorption cavity characteristics in trabecular bone: changes in primary and secondary osteoporosis.
Croucher PI; Garrahan NJ; Compston JE
Bone; 1993; 14(3):449-54. PubMed ID: 8363891
[No Abstract] [Full Text] [Related]
43. The effect of resorption cavities on bone stiffness is site dependent.
Vanderoost J; van Lenthe GH
Comput Methods Biomech Biomed Engin; 2014; 17(13):1483-91. PubMed ID: 23282095
[TBL] [Abstract][Full Text] [Related]
44. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
45. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
Yajima A; Inaba M; Tominaga Y; Ito A
Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
[TBL] [Abstract][Full Text] [Related]
46. Azotaemic renal osteodystrophy: a quantitative study on iliac bone.
Ellis HA; Peart KM
J Clin Pathol; 1973 Feb; 26(2):83-101. PubMed ID: 4696838
[TBL] [Abstract][Full Text] [Related]
47. Improvement in the anemia of hemodialyzed patients following subtotal parathyroidectomy. Evidence for the role of secondary hyperparathyroidism in the etiology of the anemia of chronic renal failure.
Shasha SM; Better OS; Winaver J; Chaimovitz C; Barzilai A; Erlik D
Isr J Med Sci; 1978 Mar; 14(3):328-32. PubMed ID: 640816
[TBL] [Abstract][Full Text] [Related]
48. Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure.
Pechalova PF; Poriazova EG
Acta Medica (Hradec Kralove); 2013; 56(2):83-6. PubMed ID: 24069663
[TBL] [Abstract][Full Text] [Related]
49. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption.
Boonen S; Broos P; Verbeke G; Aerssens J; Van Herck E; Jans I; Dequeker J; Bouillon R
J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M286-93. PubMed ID: 9310082
[TBL] [Abstract][Full Text] [Related]
50. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure].
Oliveri B; Wittich AC; Nadal MA; Zeni SN
Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710
[TBL] [Abstract][Full Text] [Related]
51. Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy.
Langub MC; Koszewski NJ; Turner HV; Monier-Faugere MC; Geng Z; Malluche HH
Kidney Int; 1996 Aug; 50(2):515-20. PubMed ID: 8840280
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis and treatment of Sagliker syndrome: a case series from Iran.
Mohebi-Nejad A; Gatmiri SM; Abooturabi SM; Hemayati R; Mahdavi-Mazdeh M
Iran J Kidney Dis; 2014 Jan; 8(1):76-80. PubMed ID: 24413727
[TBL] [Abstract][Full Text] [Related]
53. Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.
Baskin E; Ozen S; Karçaaltincaba M; Besbas N; Saatci U; Düzova A; Agras PI; Haliloglu M; Bakkaloglu A
Int Urol Nephrol; 2004; 36(1):113-8. PubMed ID: 15338687
[TBL] [Abstract][Full Text] [Related]
54. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
[TBL] [Abstract][Full Text] [Related]
55. Brown tumor in secondary hyperparathyroidism causing acute paraplegia.
Bohlman ME; Kim YC; Eagan J; Spees EK
Am J Med; 1986 Sep; 81(3):545-7. PubMed ID: 3752152
[TBL] [Abstract][Full Text] [Related]
56. Severe renal osteodystrophy in a pediatric patient with end-stage renal disease: Sagliker syndrome?
Yavascan O; Kose E; Alparslan C; Sirin Kose S; Bal A; Kanik A; Aksu N
J Ren Nutr; 2013 Jul; 23(4):326-30. PubMed ID: 23026501
[TBL] [Abstract][Full Text] [Related]
57. Locked metacarpophalangeal joint associated with PAX2 gene mutation: a case report.
Atlan F; Oberlin C; Durand S
J Hand Surg Eur Vol; 2010 Jul; 35(6):517-9. PubMed ID: 20591936
[No Abstract] [Full Text] [Related]
58. [Direct effects of vitamin D on bone].
Kazama JJ
Clin Calcium; 2004 Sep; 14(9):27-30. PubMed ID: 15577106
[TBL] [Abstract][Full Text] [Related]
59. Marked facial enlargement in secondary hyperparathyroidism.
Benjelloun M; Tarrass F; Alaoui L; Medkouri G; Hachim K; Gharbi MB; Ramdani B
Nephrol Dial Transplant; 2007 Oct; 22(10):3082-3. PubMed ID: 17636053
[No Abstract] [Full Text] [Related]
60. Bone scan appearance of renal osteodystrophy in diabetic chronic renal failure patients.
So Y; Hyun IY; Lee DS; Ahn C; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
Radiat Med; 1998; 16(6):417-21. PubMed ID: 9929141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
